DSCSA Compliance: Is Your Pharmacy Ready?
FDA guidance requires trading partners to work with authorized partners and maintain processes for suspect or illegitimate product. If your pharmacy or clinic has 25 or fewer full-time employees, the current small-dispenser date for EPCIS interoperability is November 27, 2027; other DSCSA responsibilities still apply. Use this hub as an educational starting point and verify requirements for your business with the FDA or a qualified advisor.
What's in the free checklist:
- Phased enforcement timeline through Nov 27, 2027
- Step-by-step serialization verification checklist
- T2 documentation requirements and 6-year retention rules
- Common DSCSA failure points and how to fix them
See Exactly Where You Stand
Why pharmacies and clinics choose Premier Pharma for DSCSA compliance
Verified Accredited Wholesale Distributor — the highest accreditation a drug wholesaler can earn from the National Association of Boards of Pharmacy.
Learn how Transaction Information (TI) and Transaction Statements (TS) fit into a DSCSA recordkeeping workflow.
Account credentials are reviewed before activation so eligible businesses can discuss the right ordering and workflow next steps.
Ready to put the guidance into a workflow?
The free Premier Pharma account includes starter compliance software after business verification. It can help your team organize transaction and receiving workflows; it is not a compliance certification or substitute for official guidance.
- Free account with no credit card or purchase required
- Included starter compliance software
- Credential review typically takes 1–2 business days
- Optional paid products for expanded workflows
Executive summary
What pharmacy teams should verify now
- Confirm every trading partner is appropriately authorized before exchanging covered prescription drugs.
- Maintain processes for identifying, investigating, and responding to suspect or illegitimate product.
- Review transaction-data retention and retrieval procedures with the teams responsible for receiving and dispensing product.
- Eligible small dispensers should prepare for the November 27, 2027 interoperability date while continuing to meet other applicable obligations.
Not sure where to start? Read these guides.
Detailed guides for every DSCSA requirement — written for pharmacists, not lawyers.
DSCSA Serialization Requirements for Pharmaceutical Distributors
DSCSA serialization requires a unique product identifier on every drug package. Learn who must comply and the small-dispenser deadline of November 27, 2027.
DSCSA T2 Documents — Transaction Information & Statement
Every DSCSA drug transfer requires a Transaction Information (TI) and Transaction Statement (TS). Learn what each must contain and how long to retain records.
DSCSA Track-and-Trace — End-to-End Pharmaceutical Traceability
DSCSA track-and-trace creates a unit-level pedigree for every prescription drug. Small dispensers must comply by Nov 27, 2027. Learn how it affects pharmacies.
DSCSA Requirements for Wholesale Drug Distributors
Wholesale distributors have important DSCSA responsibilities. Learn ATP verification, suspect product reporting, and VAWD accreditation requirements.
DSCSA Saleable Returns — Requirements for Returned Pharmaceutical Products
DSCSA imposes verification requirements before returned drug products can be resold. Learn what wholesale distributors and pharmacies must do to comply.
DSCSA Trading Partner Verification — How to Confirm Your Suppliers Are Authorized
Learn how to verify supplier licenses, what qualifies as an Authorized Trading Partner, and the red flags that indicate an unauthorized pharmaceutical source.
Explore the DSCSA topic areas
A practical next step
The FDA extended the small-dispenser deadline to November 27, 2027. The exemption is automatic for eligible small dispensers, but authorized-partner checks and suspect-product procedures remain important. Use the checklist to organize a review, then see the free account and included starter software when you are ready.
DSCSA Frequently Asked Questions
Key requirements, deadlines, and enforcement considerations for pharmacies.
What does DSCSA require for pharmacies?
DSCSA requires pharmacies to accept only serialized prescription drug product from authorized trading partners, retain T2 transaction records (TI + TS) for 6 years, be able to quarantine and investigate suspect product, and notify the FDA within 24 hours of identifying illegitimate product. Dispensers with 26 or more full-time employees became fully subject to these requirements on November 27, 2025. Small dispensers with 25 or fewer full-time pharmacy employees received a one-year extension and must comply by November 27, 2027.
When is the DSCSA deadline for small pharmacies?
The current small-dispenser date for EPCIS interoperability is November 27, 2027 for pharmacies with 25 or fewer full-time pharmacy employees. The exemption is automatic; no FDA filing is required. Confirm current dates and requirements with FDA guidance.
What are the penalties for DSCSA violations?
Civil penalties for DSCSA violations can reach $250,000 for a first offense and $1,000,000 for repeated violations. Serious violations involving controlled substances can result in criminal prosecution. State boards of pharmacy may also take separate licensing action.
Watch: How to Close Every DSCSA Gap Before Your Next Inspection
See how a structured workflow can help teams organize serialization verification, T2 documentation, and EPCIS interoperability work. Product capabilities and eligibility should be confirmed during the account review.
DSCSA readiness resources
Free checklist — no account needed